Life sciences and biotech £86bn boost to science and tech in the UK to turbocharge economy £86bn to fund everything from new drug treatments and longer-lasting batteries to new AI breakthroughs to generate billions for the UK economy and drive our Plan for Change Latest Content Siemens acquires Dotmatics Elsevier launches ScienceDirect AI to transform research Elsevier introduces Embase AI New technologies Solution Accelerators for biotech research Merz consolidates its R&D with a Life Sciences platform White papers Standardization of Analytical Data: Best Practices Standardization is critical to extracting the full potential of data. This White Paper offers a comprehensive guide to overcoming challenges and driving progress in analytical chemistry and beyond. Advancing the use of emerging computing infrastructure in Life Sciences RCH Solutions supports the adoption of novel computing technologies such as cloud, quantum, AI and edge computing paradigms through a co Boosting productivity of monoclonal antibody development using Chromeleon CDS: A collaboration to move biopharma forward Using the right tools is of paramount importance in the effort to advance tomorrow’s therapies. Webcasts On Demand Webinar: Consolidating computing resources can democratise research infrastructure More content Siemens acquires Dotmatics Elsevier launches ScienceDirect AI to transform research Elsevier introduces Embase AI Laser-based computing start-up wins World Economic Forum recognition IonQ to buy Oxford Ionics for $1 billion to expand quantum computing research Join our roundtable on data storage challenges in scientific research UK invests £750 million in new national supercomputing resource £86bn boost to science and tech in the UK to turbocharge economy Sussex researchers’ record discovery detects tiny electric fields 100-times more effectively – with ‘exciting’ potential to revolutionise brain scanning Machine learning algorithm brings long-read sequencing to the clinic Dassault Systèmes launch nationwide Health Data Warehouse in France Two QuEra contributions move to phase three of Wellcome Leap's Quantum for Bio Challenge Pagination Page 1 Next page Next ›
